4530 — Hisamitsu Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- ¥312bn
- ¥189bn
- ¥156bn
- 95
- 45
- 89
- 91
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.33 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -0.99% | ||
| Dividend Yield (f) | 2.85% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.12 | ||
| Price to Tang. Book | 1.15 | ||
| Price to Free Cashflow | 62.33 | ||
| Price to Sales | 1.99 | ||
| EV to EBITDA | 7.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.27% | ||
| Return on Equity | 7.97% | ||
| Operating Margin | 11.89% | ||
Financial Summary
| Year End 28th Feb | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 114,510 | 120,193 | 128,330 | 141,706 | 156,006 | 165,500 | 172,000 | 2.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -49.97 | +9.5 | +20.38 | +29.76 | +57.87 | -0.63 | -2.94 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
Directors
- Kazuhide Nakatomi PRE (49)
- Kosuke Sugiyama SMD (69)
- Shinichiro Takao MDR (66)
- Tetsuo Akiyama SME (70)
- Naruhito Higo SME (58)
- Katsuhiko Akiyama SEO
- Akira Kayashima SEO
- Koji Takiyama SEO (49)
- Katsuhiro Sato DSL
- Shinichi Murayama EXO (53)
- Kyu Saito EXO (58)
- Nobuo Tsutsumi EXO (57)
- Hidenao Minami EXO
- Masaya Okuno EXO
- Taro Ozaki EXO (50)
- Takaaki Terahara EXO
- Mitsutoshi Tsuruta EXO
- Sakae Yano EXO
- Yuichiro Anzai IND (75)
- Tetsugo Matsuo IND (49)
- Teijiro Furukawa NID (86)
- Isao Ichikawa NID (93)
- Last Annual
- February 28th, 2025
- Last Interim
- February 28th, 2025
- Incorporated
- May 22nd, 1944
- Public Since
- September 1st, 1962
- No. of Employees
- 2,759
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 72,962,768
- Address
- 30F, Marunouchi Bldg., 2-4-1, Marunouchi, CHIYODA-KU, 100-6221
- Web
- https://www.hisamitsu.co.jp/
- Phone
- +81 352931700
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4530
Q1 2026 Hisamitsu Pharmaceutical Co Inc Earnings Release
Q1 2026 Hisamitsu Pharmaceutical Co Inc Earnings Presentation (Japanese)
Dividend For 4530.T - 15.0000 JPY
Dividend For 4530.T - 45.0000 JPY
Q2 2026 Hisamitsu Pharmaceutical Co Inc Earnings Release
Similar to 4530
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Hisamitsu Pharmaceutical Co share price?
As of Today at 21:07 UTC, shares in Hisamitsu Pharmaceutical Co are trading at ¥4,264. This share price information is delayed by 15 minutes.
How has the Hisamitsu Pharmaceutical Co share price performed this year?
Shares in Hisamitsu Pharmaceutical Co last closed at ¥4,264 and the price had moved by +14.93% over the past 365 days. In terms of relative price strength the Hisamitsu Pharmaceutical Co share price has outperformed the Nikkei 225 Index by +21.12% over the past year.
What are the analyst and broker recommendations for Hisamitsu Pharmaceutical Co?
The overall consensus recommendation for Hisamitsu Pharmaceutical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hisamitsu Pharmaceutical Co dividend yield?
The Hisamitsu Pharmaceutical Co dividend yield is 2.02% based on the trailing twelve month period.
Does Hisamitsu Pharmaceutical Co pay a dividend?
Last year, Hisamitsu Pharmaceutical Co paid a total dividend of ¥86, and it currently has a trailing dividend yield of 2.02%.Looking ahead, shares in Hisamitsu Pharmaceutical Co are due to go ex-dividend on 2025-08-28 and the next dividend pay date is 2025-05-23.
When does Hisamitsu Pharmaceutical Co next pay dividends?
Hisamitsu Pharmaceutical Co are due to go ex-dividend on 2025-08-28 and the next dividend pay date is 2025-05-23. The historic dividend yield on Hisamitsu Pharmaceutical Co shares is currently 2.02%.
How do I buy Hisamitsu Pharmaceutical Co shares?
To buy shares in Hisamitsu Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hisamitsu Pharmaceutical Co?
As of the previous close price of ¥4,264, shares in Hisamitsu Pharmaceutical Co had a market capitalisation of ¥312bn.
Where are Hisamitsu Pharmaceutical Co shares listed?
Here are the trading details for Hisamitsu Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4530
What kind of share is Hisamitsu Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Hisamitsu Pharmaceutical Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hisamitsu Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in Hisamitsu Pharmaceutical Co is ¥4,843. That is 13.58% above the last closing price of ¥4,264.
Analysts covering Hisamitsu Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥299 for the next financial year.
Find out moreWhat is the trend in the Hisamitsu Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hisamitsu Pharmaceutical Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +7.64%.
As of the last closing price of ¥4,264, shares in Hisamitsu Pharmaceutical Co were trading +2.31% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hisamitsu Pharmaceutical Co PE Ratio?
The Hisamitsu Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 14.33. The shares last closed at ¥4,264.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hisamitsu Pharmaceutical Co?
Hisamitsu Pharmaceutical Co's management team is headed by:
- Kazuhide Nakatomi - PRE
- Kosuke Sugiyama - SMD
- Shinichiro Takao - MDR
- Tetsuo Akiyama - SME
- Naruhito Higo - SME
- Katsuhiko Akiyama - SEO
- Akira Kayashima - SEO
- Koji Takiyama - SEO
- Katsuhiro Sato - DSL
- Shinichi Murayama - EXO
- Kyu Saito - EXO
- Nobuo Tsutsumi - EXO
- Hidenao Minami - EXO
- Masaya Okuno - EXO
- Taro Ozaki - EXO
- Takaaki Terahara - EXO
- Mitsutoshi Tsuruta - EXO
- Sakae Yano - EXO
- Yuichiro Anzai - IND
- Tetsugo Matsuo - IND
- Teijiro Furukawa - NID
- Isao Ichikawa - NID